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Graphical Abstract 
 
Abstract.  Although buffer-specific effects on molecular recognition are known 
in biological science, they remain rare in supramolecular chemistry.  The binding 
between a cationic dye, Mallard Blue (MalB), and polyanionic heparin in 
aqueous NaCl (150 mM) is studied in three commonly-used buffers (Tris-HCl, 
HEPES, Phosphate, each 10 mM).  Although MalB has a very similar UV-Vis 
spectrum in each buffer, the sensory response towards heparin was different in 
each case.  This can be ascribed to differences in the complex formed.  In Tris-
HCl which has the least competitive chloride counter-anions, MalB exhibits a 
hypsochromic shift of 25 nm, assigned to strong binding and aggregation of the 
dye on heparin.  In more competitive HEPES, containing a sulfonate anion, there 
is weaker binding and less aggregation of MalB along the heparin; the 
hypsochromic shift is only 15 nm.  In phosphate buffer, MalB can interact quite 
strongly with buffer phosphate anions; although heparin binding is still observed, 
the hypsochromic shift associated with dye aggregation is only 5 nm.  As such, 
specific buffer interactions with the MalB-heparin complex mediate host-guest 
binding and sensing.  Buffer choice must be made carefully in studies of 
molecular recognition ± we would caution against using phosphate and sulfonate 
containing buffers when studying electrostatic binding. 
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Introduction 
 
When studying biologically relevant binding, or developing supramolecular systems 
which can mimic or intervene in such processes, it is necessary to work in highly 
challenging and competitive aqueous media (1).  In addition to water, such binding 
events must also often remain robust in the presence of high levels of salt, and buffers 
which help control pH.  It is well-known that electrolyte can impact on binding 
affinities either through charge-screening effects (2) or via the Hofmeister series (3).  
Ong and Kaifer explored the impact of the presence of ions on cucurbituril binding to 
viologens and found decreasing binding strengths as the ionic strength increased, with a 
dependence also on the charge of the competing cation (4).  The importance of this was 
emphasised by Verboom and co-workers who studied the impact of counter-ions on 
electrostatic self-assembly (5).  This type of effect has recently been revisited by 
García-Río and co-workers in the context of binding constant determination (6).  We 
have also explored ionic strength effects on binding between cationic dendrons and 
DNA, and elucidated the impact of electrolyte on multivalent electrostatic interactions 
(7,8).  However, the impacts of buffers on molecular recognition processes are less 
often explored. 
 
As long ago as 1966, Good and co-workers discussed the appropriate choice of buffers 
and outlined a series of criteria for preferred buffers (9-11): (i) pH values between 6 and 
8, (ii) maximum water solubility and minimum lipid solubility, (iii) minimal influence 
of temperature, ionic strength or buffer concentration on pKa, (iv) non-complexing 
towards metal ions, (v) stable, (vi) non-absorbing to light > 240 nm, (vii) cheap and 
easy to prepare.  Furthermore, in biological studies, the potential for buffers to have 
specific effects is amplified.  For example, certain buffers can induce protein folding or 
unfolding (12), which can have dramatic effects on protein-protein interactions as well 
as modifying other binding events.  In addition, when working in living systems, buffers 
can interact with cell membrane components (13) and even have impacts on cell growth 
and survival (14). 
 
In an outstanding review article from 2015, Soares and co-workers grappled further 
with this topic, considering data for a wide range of commercially available buffers and 
their relative (un)suitability for studies of biological, biochemical and environmental 
systems (15).  ,QSDUWLFXODUWKH\QRWHGWKDWHYHQDPRQJVW*RRG¶VEXIIHUVVLJQLILFDQW
differences could occur, and that this was a key factor in metal-dependent binding 
processes as a consequence of metal-buffer interactions.  Indeed, such factors have long 
been recognised to be important in metal-coordination chemistry, particularly when 
binding constants are being derived.  With metal binding in mind, there have recently 
been reports in which changing the buffer can alter the metal selectivity of 
supramolecular metal sensors (16-18).  However, these buffer effects have not been 
explored systematically. 
 
It is likely that buffer choice can also have significant impacts on many processes which 
are not metal dependent, and it is fair to say that in general terms, the importance of 
buffers is less often discussed in the area of supramolecular chemistry than in the fields 
of bioscience or metal coordination chemistry.  Indeed, the choice of buffer for studies 
of molecular recognition in water is rarely commented on, other than by way of a 
simple statement of which buffer was used.  Influential reviews from 2007 and 2010 
dealing with supramolecular chemistry in water (19) and aqueous anion binding (20), 
and a recent review from 2015 describing anion binding in water (21) indicate that a 
very wide range of buffers are used in binding studies.  However, there were no specific 
comments in these reviews addressing the impact this may have. 
 
A rare example of a buffer effect in supramolecular chemistry was reported by Sirish 
and Schneider in 2000, who demonstrated that for the interaction of cationic porphyrins 
with a variety of small phosphate anions, the presence of phosphate buffer at increasing 
(and high) concentrations 0.1 M and 0.3 M had a significant impact on binding affinity 
and mode, with lipophilic interactions gaining in importance as the concentration of 
phosphate buffer increased (22).  However, this was primarily due to the impact of ionic 
strength, and as noted above, such effects on molecular recognition are relatively well-
known, particularly in the field of electrostatic binding (2, 4-8).  In very rare cases, 
authors have commented on specific buffer effects, such as Rebek and co-workers, who 
noted in passing in WKDWIRUUHDVRQVZKLFKZHUHµQRWUHDGLO\XQGHUVWRRG¶WKHLU
hydrophobic hosts showed different binding strengths and selectivities towards 
adamantane guests in pure water, tris buffer and phosphate buffer (23). 
 
As noted earlier, in biomolecular recognition, such effects are much better recognised ± 
the impact of this has been recently highlighted by Salis and Monduzzi, in an excellent 
review discussing the importance of buffer-specific effects in the biosystems analysis 
(24). To exemplify this, Baaske and co-workers developed a specific assay to determine 
the buffer dependence of aptamer binding (25).  Given the emerging importance of 
fusing supramolecular chemistry with biology (1), and the fact that biological chemists 
are increasingly exploring specific ion and buffer effects at binding interfaces (26), it is 
clear that supramolecular chemists need to increasingly think very carefully about the 
environment in which molecular recognition is taking place.  Any assumption that all 
aqueous solutions behave similarly is clearly insufficient ± as such, it is perhaps 
surprising that supramolecular chemists have focussed relatively little attention on the 
roles which buffers can play. 
 
Electrostatic binding is of key importance in biological processes, as it can deliver 
relatively large amounts of binding affinity even in competitive aqueous media (27).  
,QWHUHVWLQJO\LWKDVEHHQQRWHGWKDWPXFKRIELRORJ\LVDµSRO\DQLRQZRUOG¶ZLWKDZLGH
range of polyanionic species being of interest ± including nucleic acids, 
glycosaminoglycans, proteoglycans, microtubules and filaments and cell membranes 
(28).  Remarkably, biology is able to control these different nanoscale polyanionic 
species with a good degree of precision.  Furthermore, biology has to achieve this in the 
presence of many potential competitor species. 
 
One of our specific polyanionic binding targets of interest is heparin (Fig. 1), a key 
glycosaminoglycan used during major surgery to prevent blood clotting (29).  Effective 
sensors for this polyanion have potential clinical importance so that anesthetists can 
rapidly determine how much heparin is present in a patient to ensure optimal clotting 
behaviour throughout and after surgery (30).  We developed the sensor Mallard Blue 
(MalB, Fig. 1), a thionine unit functionalised with arginine amino acids, which responds 
to heparin through a distinctive change in its UV-visible spectrum (31,32). This sensor 
relies on well-organised electrostatic interactions between its cationic groups and the 
anionic sites on the heparin, and can operate at clinically relevant concentrations in 
highly competitive conditions, such as the presence of 150 mM NaCl and/or human 
serum.  In this field of research, there has been considerable focus on developing 
systems which operate effectively in competitive media (33-39) as replacements for 
simple dyes such as Azure A (40) which are unable to function under such challenging 
conditions.  As such, the robustness of heparin sensors to environmental conditions is of 
key importance. 
 
 
Figure 1.  Structures of Mallard Blue, heparin (highlighting the major disaccharide 
repeat unit and the active pentamer which binds antithrombin III), and buffers used in 
this study.  Molecular dynamics model of Mallard Blue binding to heparin reproduced 
from reference (31) with kind permission of American Chemical Society. 
 
Given the fact that different aqueous solutions can be very different, and buffer may 
have significant impacts on binding, we therefore wanted to explore the impact of 
buffer on MalB.  In particular we wished to compare the binding and sensing in 
different buffers.  Further, we aimed to do this in the presence of a high concentration of 
NaCl (150 mM) such that the impact of buffer could not simply be assigned to changes 
in ionic strength ± in our approach the ionic strength is kept approximately constant by 
the large excess of salt.  In this way, we hoped to determine whether buffers were 
having particular effects on binding and sensing as a result of specific interactions with 
the host and/or guest.  Given the relative paucity of reports in which buffer choice has a 
direct impact on supramolecular binding, we report the results here, and consider their 
general implications and significance. 
 
Results and Discussion 
 
A binding study of MalB with heparin in different buffer systems was performed using 
UV-Vis spectroscopy.  Specifically, we chose the three most commonly used buffers in 
supramolecular and biological science ± Tris-HCl, HEPES and Phosphate buffer (Fig. 
1).  In each case, the pH of the solution was 7.0 and buffers were applied at 10 mM 
concentration ± sufficient to control pH during the titration experiment, but well below 
the 150 mM concentration of NaCl which was also present in the assay to control ionic 
strength.  The concentration of MalB was 25 PM and heparin was titrated into the 
sample.  MalB was also present in the titrant, so there were no dilution effects during 
the titration.  Calculating the concentration of heparin is relatively challenging, as it is a 
polydisperse anion with a variety of repeat units, and there is sample-to-sample 
variability in terms of its make-up.  We assumed for the calculations, a molecular mass 
which corresponds to the most commonly occurring dimeric saccharide heparin repeat 
unit.  All titrations were repeated in triplicate on separate samples and showed very 
good reproducibility. 
 
 
Figure 2. UV-Vis absorbance of Mal-B with increasing heparin concentration in (A) 
Tris-HCl buffer, 10 mM, pH 7, 150 mM NaCl; (B) HEPES buffer, 10 mM, pH 7, 150 
mM NaCl; (C) Phosphate buffer, 10 mM, pH 7, 150 mM NaCl. 
 
Studies of MalB binding heparin in Tris-HCl buffer have previously been reported by us 
(31) and our results here were in agreement with them (Fig. 2A).  As can be seen, there 
is a decrease in absorbance on addition of heparin to MalB, and the max absorbance 
wavelength (Omax) shifts from 612 to 587 nm as the concentration of heparin increases ± 
a hypsochromic shift of 25 nm.  The reasons for this are discussed in more detail below.  
A similar effect was observed on the titration of heparin into MalB in HEPES buffer 
(Fig, 2B), however in this case the  Omax only shifted from 612 to 598 nm ± a 
hypsochromic shift of just 14 nm.  In the case of the titration performed in phosphate 
buffer, the UV response to heparin binding was more significantly different.  Although 
the absorbance decreased, this was a much less significant decrease than in the other 
two buffer systems.  Furthermore, the Omax value only shifted from 612 nm to 607 nm ± 
just a 5 nm hypsochromic shift.  There are clearly some subtle and important differences 
between the way in which MalB binds heparin in the different buffer systems. 
 
 
Figure 3.  Binding profiles for MalB titrated with heparin, extracted at 615 nm, in 
different buffer systems ± Tris-HCl, HEPES and Phosphate ± all in the presence of 150 
mM NaCl. 
 
Figure 3 presents the binding profiles for each of these titration events in the different 
buffers with average normalised data extracted from the spectra at 615 nm.  It is clear 
from the binding profiles that the binding curves have similar endpoints when the 
titration is performed in Tris-HCl or HEPES, but a significantly different one when 
carried out in phosphate buffer.  As such the titration curves suggest that the phosphate 
buffer is having the most significant impact on the binding event (see below) ± in 
agreement with the observed hypsochromic shifts. 
 
More detailed inspection of the binding curves between MalB and heparin in Tris-HCl 
and HEPES would suggest that the binding profile is sharper in Tris-HCl, and hence the 
binding is stronger, with the binding profile being shallower in HEPES, suggestive of 
weaker binding.  Furthermore, it appears by inspection that the binding event in 
phosphate buffer is weaker again, with a shallower titration profile.  It is, however, 
somewhat problematic to assign numerical binding constants to these processes for a 
number of reasons:  
(i) Binding is taking place to a polymer, and it is unclear what the precise 
stoichiometry of binding is ± furthermore, it appears this is slightly different 
in each buffer (see below), 
(ii) Heparin is polydisperse, with different repeat units, and hence chemically 
different sites on the polymer, each of which will have different affinities for 
MalB, varying through the titration, 
(iii) When more MalB is bound to the polymer (at low heparin concentrations) each 
binding event will have a different affinity owing to MalB-MalB interactions 
when the MalB units are in close proximity on the heparin chain ± once 
again, the binding affinity will vary through the titration dependent on the 
degree of loading. 
As such, it can be difficult to extract meaningful binding constants ± and we were 
unable to do so in a meaningful way.  In particular, we noted that in each buffer, the 
apparent binding stoichiometry was slightly different.  Finding the approximate 
saturation point in each case, it became clear that in Tris-HCl, more heparin had to be 
added to saturate the response of MalB than in either of the other buffers.  
Approximately 20 PM of heparin (concentration reported as the typical dimer) saturates 
MalB in TrisHCl, whereas this falls to 15 PM in HEPES or phosphate buffer.  This 
means that one equivalent of MalB binds to every 2.5 saccharide units on heparin in 
Tris HCl, falling to only one MalB to every 3.3 heparin saccharide units in the other 
buffers.  This suggests that in some way, the buffer is mediating the interactions 
between MalB and heparin, and as a result modifying the loading of MalB onto the 
polyanion and hence the apparent stoichiometry of the complex (see below for further 
discussion). 
   
We then measured the UV-Vis spectra of MalB on changing the ratio of Tris-
HCl:phosphate buffers ± the two extreme cases.  For MalB alone, in the absence of 
heparin, the Omax  and absorbance did not significantly shift as the amount of phosphate 
anion increased from 0 to 10 mM (Fig. 4A).  Given that at pH 7.4, phosphate anions are 
a mixture of H2PO4- and more highly charged HPO42-, it might have been expected that 
they bind more strongly to MalB than the surrounding Cl- ions in the NaCl.  However, 
Figure 4A clearly demonstrates that if phosphate does bind to MalB, this does not have 
any impact on the UV-Vis spectroscopic properties.   
 
 
Figure 4. UV absorbance in different ratios of buffer (1:0 to 0:1 phosphate:Tris-HCl) of 
(A) MalB (25 PM) indicating little impact on the UV-Vis spectrum, and (B) MalB (25 
PM) fully complexed to heparin (25 PM), indicating that in Tris-HCl the complex 
absorbs at shorter wavelength and with lower intensity. 
 
However in the presence of heparin, switching the buffer between phosphate and Tris-
HCl had a major effect on the spectroscopic properties.  As the level of Tris-HCl was 
increased (and the phosphate content decreased), there was a shift in Omax from 612 to 
587 nm, and a decrease in the absorbance (Fig. 4B).  It is therefore clear, that the 
differences in the titration responses discussed above are a direct result of the differing 
optical properties of the MalB-heparin complexes in the different buffers, and do not 
reflect differences in the optical properties of MalB alone.  Furthermore, based on the 
titration data, HEPES lies in-between the extremes of Tris-HCl and phosphate buffers in 
terms of its impact on the MalB-heparin complex optical properties. 
 
Given that we are performing the studies in an aqueous solution of 150 mM NaCl, and 
studying all three buffers at the same concentration (10 mM) we can rule out any 
possibility that the effect of buffer is a result of ionic strength.  We can also rule out 
cation-derived effects associated with the phosphate buffer, as the cation is sodium ± the 
same as present in the supporting electrolyte (NaCl).  As such, it seems likely that the 
impact of the buffer is associated with its anionic character ± phosphate, sulfonate 
(HEPES) or chloride (Tris-HCl). 
 
The observations agree with the expectations we may have of these buffers as 
phosphate>sulfonate>chloride in terms of potential for interaction with cationic sites.  
This is a result of (i) the higher charge of phosphate at physiological pH making it the 
most strongly binding anion, followed by (ii) the greater propensity of both phosphate 
and sulfonate to form directional hydrogen bonds and hence out-compete the supporting 
electrolyte (chloride).  We would expect that Tris-HCl should have effectively no anion-
mediated effect on binding, as the chloride of this buffer is matched with the supporting 
electrolyte. 
 
We therefore need to understand why these anions have an impact on the UV-vis 
spectra of MalB, but only when complexed to heparin.  Naively, it might be expected 
that on binding to heparin, any interactions with the surrounding buffer will be 
displaced DVDUHVXOWRIKHSDULQ¶VJUHDWHUFKDUJHGHQVLW\.  However, the concentration of 
the heparin in these experiments is only ca. 20 PM at the saturation point (60-80 PM per 
negative charge), whereas the concentration of the buffer anion is 10 mM; >100-fold 
excess.  In this context, it is actually remarkable that MalB still shows highly effective 
heparin binding, even in the presence of such a large excess of phosphate anions.  It 
does, however, allow us to propose their direct involvement in the overall complex 
which is formed. 
 
It is well-known that this type of dye exhibits absorbance bands associated with the 
monomer at longer wavelength, but on the formation of dimers has a shorter wavelength 
absorbance (41).  Indeed, it has been known for many years that this dimerisation 
process and spectroscopic shift is encouraged, even for simple cationic dyes such as 
unfunctionalised thioine, on binding to polyanions ± a process referred to as 
metachromasia (42-44).  In buffered solution, irrespective of buffer choice, MalB is 
therefore present as a monomer with an emission band of 612 nm.  The monomer may 
be bound to anionic constitutents in the buffer (such as phosphate or sulfonate), but this 
does not cause aggregation of the dye, and as such, has no impact on the optical 
properties.  On binding to heparin, MalB dyes are brought into closer proximity with 
one another, and effectively form H-type dimers (41), pre-organised on the polyanionic 
heparin chain (Fig, 5, left).  This explains the hypsochromic shift of 25 nm when 
heparin is added to MalB in Tris-HCl.  However, in the presence of phosphate anions, 
binding of phosphate to MalB can limit the extent of MalB binding along the heparin 
chain, and hence the extent of dimer formation (Fig. 5, right) ± as such, the 
hyposchromic shift is therefore limited to just 5 nm, and the change in absorbance 
spectrum is much smaller.  This model is in agreement with the apparent 
stoichiometries observed in the titration curves (Fig. 3) and discussed above.  In 
HEPES, interactions between MalB and sulfonate somewhat, but not completely, limit 
heparin binding and MalB dimersiation, and hence the change in optical properties is 
intermediate between the extremes observed in Tris-HCl and Phosphate buffers, with a 
hypsochromic shift of 14 nm. 
 
 
Figure 5.  Schematic of Mallard Blue (crescent-shaped) binding to heparin in different 
buffers.  In Tris-HCl, the chloride anions act as innocent spectatators, and enable 
effective binding and aggregation of MalB, while in phosphate buffer, the phosphate 
anions are intimately involved in interactions with MalB in the complex, and hence 
limit the sensory response of the dye. 
 
 ,QWKLVZD\WKHPRUHLQWHUDFWLYHEXIIHUDQLRQVHIIHFWLYHO\µVROYDWH¶WKH0DO%DQGOLPLW
its binding to, and organisation on, the heparin polyanion, which is responsible for the 
sensing response.  This hypothesis is in agreement with the stoichiometric observation 
that more heparin binds to MalB in Tris-HCl than in the other two buffers ± in the other 
buffers, MalB is also interacting with the buffer anions present ± hence limiting the 
interactions with heparin and leading to its saturation at lower heparin loadings. 
 
Conclusions 
 
The results of this study demonstrate that the choice of buffer is essential when 
considering host-guest interactions in aqueous systems.  This binding event was based 
on electrostatics, and  these results particularly highlight the ability of anionic 
components in buffer to mediate complexation events and modify host-guest complexes 
as a result of their specific ability to interact with the complex.   
 
Interestingly, although both Tris-+&ODQG+(3(6DUHERWKFODVVLILHGDV*RRG¶VEXIIHUV
(9-11), in this case, Tris-HCl is effectively non-interactive, and acts as an innocent 
spectator, whereas HEPES becomes somewhat involved in the recognition event, 
lowering the binding strength (see above) and changing the sensory response.  This 
ZRXOGVXSSRUWWKHUHFHQWUHYLHZDUWLFOHZKLFKQRWHGWKDWQRWDOORI*RRG¶VEXIIHUVFDQ
be considered equally good for understanding biological and biochemical processes 
(15,24)XUWKHUPRUHIRUSKRVSKDWHZKLFKLVQRWRQHRI*RRG¶VEXIIHUVWKLVHIIHFWLV
even more significant and the difference in the sensory response of MalB is indeed quite 
dramatic. The low suitability of phosphate buffers for metal-binding processes is well-
known, but this has not clearly been stated for supramolecular electrostatic binding 
events.  Furthermore, phosphate buffers remain the first choice in many biochemical 
studies.  As a result of this study, we would caution against the use of phosphate buffers 
(and to some extent sulfonate buffers) when investigating binding processes with 
electrostatic character. 
 
All of the buffers used in this study were very standard buffers, frequently considered 
for use in binding assays ± as such, we encourage supramolecular chemists to select 
buffers carefully, and remember they may play active roles in the molecular recognition 
event of interest.  Although, as outlined in the Introduction, such factors are well-known 
in biological chemistry, they are less well appreciated in supramolecular chemistry, and 
given the current drive to further extend the study of synthetic recognition processes 
into aqueous media (19-21), and to have impacts on biomedical processes (1), we 
believe these observations will be of general interest and importance to the community. 
 
Experimental 
 
Mallard Blue was synthesised according to published methods (30), and analytical data 
were in agreement with previous reports.  Solutions were always made up fresh and 
incubated for 24 hours at 50ºC prior to use, being stored in the dark.  Sodium salt heparin 
from porcine intestinal mucosa with a molecular weight between 15,000 ± 2,000 Da (1 kU 
= 1000 units) was obtained from Calbiochem. 
 
Binding of Heparin to Mal-B. A cuvette was charged with 2 mL of a stock solution of 
0DO%ȝ0LQ1D&O (150 mM) and Tris-HCl (10 mM), HEPES (10 mM) or phosphate 
EXIIHUP07KLVVROXWLRQZDVWLWUDWHGZLWKDVWRFNVROXWLRQRIKHSDULQȝ0LQ
MalB ȝ01D&OP0DQG7ULV-HCl (10 mM), HEPES (10 mM) or phosphate 
buffer (10 mM) to a final cuvette volume of 3 mL. The absorbance at 615 nm was recorded 
after each addition. Experiments were performed in triplicate.  Samples containing mixtures 
of buffers were made by mixing suitable aliquots of the appropriate buffered solutions. 
 
For the purpose of calculations, the molecular weight of heparin is assumed as that of 
the sodiated analogue of the heparin repeat unit shown in Figure 1: namely 665.40 g 
mol-1.  It should be noted that as supplied, heparin only contains ca. 30-40% of material 
with the active pentamer sequence of repeat units.  However, all of the sample contains 
anionic saccharide units which can bind, even if they are in the wrong sequence.  Hence 
to best evaluate binding stoichiometries, we report the total concentration of the anionic 
disaccharide ± irrespective of whether it is present in the active form of heparin or not.   
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